Medication info
Ibatin Tablet 4 mg (Pitavastatin Calcium Hydrate)

Ibatin Tablet 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Light yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202103366 · Approved 2021.04.26 · Insurance code 628902020

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo-B protein
  • elevated triglycerides
View approved original text

This medication helps lower total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels while raising HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, thus improving the lipid profile. It is particularly used as an adjunct to dietary therapy in cases of familial and non-familial hypercholesterolemia and Fredrickson classification type IIa and IIb, contributing to vascular health and prevention of cardiovascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium orally once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used by individuals who have had allergic reactions to it. Patients with active liver disease or consistently high liver function test results should not take it. Those with severe liver impairment or bile duct obstruction, as well as biliary obstruction, should also avoid this medication. Individuals currently taking cyclosporine should not use it concurrently. Those with myopathy-related muscle disorders should refrain from use. This medication is not recommended for pregnant women, women who may become pregnant, or nursing mothers. Safety and efficacy in children have not been established, so it should not be used in this population. This medication contains lactose, which should be avoided by those with lactose intolerance or certain genetic metabolic disorders. Allergies to soybean oil, soy, or peanuts also warrant avoidance. Individuals with renal function abnormalities should be cautious when taking this medication with other specific drugs, as muscle damage and renal function deterioration may occur. Patients with weakened liver function or a history of liver disease should use this medication cautiously, as it may burden the liver. Excessive alcohol consumption during treatment requires caution. Individuals with hypothyroidism, a family history of muscle disorders, elderly patients, and those with lipid metabolism abnormalities should also use it with care. In individuals with severe myasthenia, symptoms may worsen during use, necessitating caution. If muscle pain, weakness, or dark-colored urine occurs while taking this medication, consult a physician immediately. Regular liver function tests and blood tests are required, and if abnormalities are detected, medication should be discontinued. This medication is used for the treatment of hypercholesterolemia, so a thorough examination is necessary prior to use to confirm the condition. Dietary adjustments, exercise, and management of other risk factors should also be considered. There may be interactions with other medications, so patients must inform their healthcare provider of any concurrent medications. In particular, caution is needed when used with cyclosporine, fibrate medications, and niacin, as severe side effects may occur. This medication may have a higher incidence of side effects in older individuals, requiring potential dose adjustments. Pregnant or nursing women should avoid use due to potential risks to the fetus and infants. The tablets should be swallowed whole without chewing or splitting and kept out of reach of children.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 92 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heavy head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • fatigue
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing impairment
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • dysgeusia
  • positive antinuclear antibody
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disorders
  • loss of appetite
  • increased blood pressure
  • discomfort in the chest
  • asthenia
  • nausea
  • increased γ-GT
  • increased LDH
  • increased ALP
  • itching
  • urticaria
  • thrombocytopenia
  • increased serum creatinine
  • increased BUN
  • increased blood pressure
  • skin tingling
  • discomfort in the chest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a special container that does not allow light to enter. Additionally, when storing the medication, it is important to maintain a temperature between 1 and 30 degrees Celsius to preserve its effectiveness.

Appearance and packaging

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.